8 results
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Venous Thromboembolism ... Treatment Algorithm ... Management #VTE #DVT ... #Algorithm #Venous ... #Hematology #Anticoagulation
Treatment Algorithm for First Time DVT
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke, MD.

#DVT
Treatment Algorithm ... for First Time DVT ... #DVT #Treatment ... #hematology #VTE ... #thrombosis #venous
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for the treatment ... DVT = deep vein ... mass index; VTE = venous ... Anticoagulation #Management #Hematology ... #Oncology
â–º
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... and incidental DVT ... without concomitant DVT ... Anticoagulation #Management #Hematology ... #Oncology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous ... Thromboembolism Treatment ... Algorithm Treat ... Isolated distal DVT ... #hematology #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... PV, MDS, CML) Treatment ... • Treatment algorithms ... Thrombocythemia #ET #hematology ... diagnosis #management #hematology
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
Pain in LN on alcohol ... classical HL (MCHL ... Hodgkin Lymphoma Treatment ... classification #hematology ... #oncology #management
Myelodysplastic Syndromes (MDS)

What?
Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
Myelogenous Leukemia (CML ... arsenic compounds, alcohol ... factor (GCSF) treatments ... Syndromes #diagnosis #hematology ... #oncology